MedPath

Internet-Delivered CBT for Children With Functional Abdominal Pain Disorders

Not Applicable
Completed
Conditions
Functional Abdominal Pain Disorders
Interventions
Behavioral: Internet-delivered Cognitive behavior therapy
Registration Number
NCT02873078
Lead Sponsor
Karolinska Institutet
Brief Summary

This randomized controlled study aims to evaluate the efficacy of exposure-based Internet-delivered cognitive behavior therapy for children 8-12 years with Functional Abdominal Pain Disorders. The children participate along with their parents, who will also receive specific modules with information on how to support their children in the treatment. Predictors and mediators for treatment effects will be studied as well as the cost effectiveness of the intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
91
Inclusion Criteria
  • Children 8-12 years with either irritable bowel syndrome, functional dyspepsia or functional abdominal pain - not otherwise specified diagnosed according to Rome-III or Rome-IV criteria.
  • Psychopharmacological medication stable for at least a month if medicating.
  • Child and at least one parent speaking and writing swedish.
  • Access to computer with Internet connection.
Read More
Exclusion Criteria
  • Severe somatic disorder and/or if the child fulfills criteria of other disorder that better explains the abdominal symptoms.
  • Severe psychiatric or social problems that needs other care.
  • Ongoing psychological treatment.
  • School absenteeism more than 40 %.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Internet-delivered CBTInternet-delivered Cognitive behavior therapyChildren and parents will receive 10 weekly modules of cognitive behavior therapy (CBT). Parents will also receive 10 weekly modules. Main components in the children's modules are exposure for abdominal symptoms, feared stimuli and situations in which the children are afraid of having symptoms. The parental receive information on how they can support their children in the treatment and how to reinforce health y behaviors and decrease attention to pain behaviors. Therapist support is provided through written messages within the secure platform.
Primary Outcome Measures
NameTimeMethod
PedsQL GastroBaseline to 10 weeks, baseline to 9 months, baseline to 15 months

Change in gastrointestinal symptoms measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

Secondary Outcome Measures
NameTimeMethod
Faces Pain Rating ScaleWeekly during treatment (treatment week 1-9).

Change in pain intensity measured with a self-rating scale weekly during treatment for mediation analyses.

Faces Pain Rating Scale rated by parentsWeekly during treatment (treatment week 1-9).

Change in pain intensity measured with a self-rating scale weekly during treatment for mediation analyses.

PedsQL Gastro rated by parentsWeekly during treatment (treatment week 1-9).

Change in child gastrointestinal symptoms measured with a self-rating scale weekly during treatment for mediation.

Pediatric quality of life inventory (PedsQL QOL)Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

Change in quality of life measured measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

Pediatric quality of life inventory (PedsQL QOL) rated by parentsBaseline to 10 weeks, baseline to 9 months, baseline to 15 months

Change in child quality of life measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

Painfree daysWeekly during treatment (treatment week 1-9)

Change in pain free days measured with a self-rating scale weekly during treatment for mediation analyses.

Painfree days rated by parentsWeekly during treatment (treatment week 1-9)

Change in child's pain free days measured with a self-rating scale weekly during treatment for mediation analyses.

IBS-Behavioral responses questionnaire (IBS-BRQ)Weekly during treatment (treatment week 1-9)

Change in child's behavioral responses to abdominal symptoms measured with a self-rating scale weekly during treatment for mediation analyses.

Spence Children Anxiety Scale - short version (SCAS-S) rated by parentsBaseline to 10 weeks, baseline to 9 months, baseline to 15 months

Change in child's anxiety symptoms measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

Visceral Sensitivity IndexWeekly during treatment (treatment week 1-9)

Change in visceral sensitivity measured with a self-rating scale weekly during treatment for mediation analyses.

IBS-Behavioral responses questionnaire (IBS-BRQ) parental versionWeekly during treatment (treatment week 1-9)

Change in child's behavioral responses to abdominal symptoms measured with a self-rating scale weekly during treatment for mediation analyses.

Spence Children Anxiety Scale - short version (SCAS-S)Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

Change in child's anxiety symptoms measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

Adverse events (AE)At week 10

Adverse events during treatment measured with a self-rating scale by the parents.

Child Depression Inventory - short version (CDI-S)Baseline to 10 weeks, baseline to 9 months, baseline to 15 months

Change in child's depressive symptoms measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

Client Satisfactory Questionnaire (CSQ)At week 10

Client satisfaction rated measured with a self-rating scale

Rome-IV questionnaireBaseline to 10 weeks, baseline to 9 months, baseline to 15 months

Change in diagnostic status of functional abdominal pain disorder measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

Client Satisfactory Questionnaire (CSQ) rated by parentsAt week 10

Client satisfaction rated measured with a self-rating scale

Subjective Assessment Questionnaire (SAQ)At week 10

Subjective change in symptoms measured with a self-rating scale

Subjective Assessment Questionnaire (SAQ) rated by parentsAt week 10

Subjective change in the child's symptoms measured with a self-rating scale by the parents.

KidscreenBaseline to 10 weeks, baseline to 9 months, baseline to 15 months

Change in quality of life for use in economic evaluation measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

School absenteeism rated by parentsWeekly during treatment (treatment week 1-9)

Change in child's school absenteeism measured with a self-rating scale weekly during treatment for mediation analyses.

Working Alliance Inventory (WAI) short versionAt week 4

Working alliance in first three weeks of treatment measured with a self-rating scale by the parents.

The treatment credibility scale rated by parents.At week 2

Treatment credibility measured with a self-rating scale by the parents.

Trimbos and Institute of Technology Cost Questionnaire for Psychiatry (TIC-P) rated by parentsBaseline, at weeks 3, 7, 10 and at 9 months

Costs associated with the disorder measured with a self-rating scale by the parents.

General health questionnaire (GHQ-12) rated by parentsBaseline to 10 weeks, baseline to 9 months, baseline to 15 months

Change in general health measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

Generalised anxiety disorder assessment (GAD 7) rated by parentsBaseline to 10 weeks, baseline to 9 months, baseline to 15 months

Change in parental anxiety symptoms measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

Pain Catastrophizing Scale, parental version (PCS-P)Weekly during treatment (treatment week 1-9)

Change in parental catastrophizing of the child's symptoms measured with a self-rating scale weekly during treatment for mediation analyses.

Children´s Somatization Inventory (CSI 24) rated by parentsBaseline to 10 weeks, baseline to 9 months, baseline to 15 months

Change in child's somatization symptoms measured with a self-rating scale from baseline to 10 weeks, from baseline to 9 months, and from baseline to 15 months for analysis of effect.

Adult responses to children's symptoms (ARCS) rated by parentsWeekly during treatment (treatment week 1-9)

Change in parental responses to child's symptoms measured with a self-rating scale weekly during treatment for mediation analyses.

PedsQL GastroWeekly during treatment (treatment week 1-9).

Change in gastrointestinal symptoms measured with a self-rating scale weekly during treatment for mediation analyses.

Trial Locations

Locations (1)

Child and Adolescent Psychiatry in Stockholm

🇸🇪

Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath